Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 066348/0004 | |
| Pages: | 6 |
| | Recorded: | 02/05/2024 | | |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18000865
|
Filing Dt:
|
12/06/2022
|
Publication #:
|
|
Pub Dt:
|
05/11/2023
| | | | |
Title:
|
DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18000865
|
Filing Dt:
|
12/06/2022
|
Publication #:
|
|
Pub Dt:
|
05/11/2023
| | |
PCT #:
|
US2137261
|
Title:
|
DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION
|
|
Assignee
|
|
|
1599 CLIFTON ROAD NE, 4TH FLOOR |
ATLANTA, GEORGIA 30322 |
|
Correspondence name and address
|
|
CHENAE M. BYRD
|
|
KILPATRICK TOWNSEND & STOCKTON LLP
|
|
1100 PEACHTREE STREET NE, SUITE 2800
|
|
ATLANTA, GA 30309
|
Search Results as of:
05/29/2024 04:54 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|